NCI-designated Consortium Cancer Center
|
|
|
The UC San Diego Office of the Vice Chancellor for Health Sciences is delighted to host a series of lectures as part of the Moores Cancer Center Director recruitment effort. Each lecturer will highlight his or her personal achievements in education, research, and/or clinical care and provide a brief vision for the Moores Cancer Center.
|
|
|
|
Joseph Califano, M.D.
Physician in Chief, Moores Cancer Center
Director, Hanna and Mark Gleiberman Head and Neck Cancer Center
Co-Leader, Structural and Functional Genomics, Moores Cancer Center
Professor and Iris and Matthew Strauss Chancellor’s Endowed Chair in Head and Neck Surgery
Division of Otolaryngology - Head and Neck Surgery
Department of Surgery
UC San Diego
Wednesday, July 6, 2022
5:00 p.m. - 6:00 p.m.
ACTRI Auditorium
In-person capacity limited to 60
The seminar also will be available via Zoom:
ZOOM MEETING LINK
|
|
|
|
Ezra Cohen, M.D.
Chief, Division of Hematology/Oncology,
Department of Medicine, UC San Diego, School of Medicine
Co-Director, San Diego Center for Precision Immunotherapy
Associate Director for Clinical Science, Moores Cancer Center
Co-Leader, Solid Tumor Therapeutics Program, Moores Cancer Center
Co-Director, Hanna and Mark Gleiberman Head and Neck Cancer Center
Thursday, July 7, 2022
5:00 p.m. - 6:00 p.m.
ACTRI Auditorium
In-person capacity limited to 60
The seminar also will be available via Zoom:
ZOOM MEETING LINK
|
|
|
Accepting Applications for Associate Director,
Diversity, Equity, and Inclusion
|
|
|
|
Moores Cancer Center (MCC) is recruiting an Associate Director of Diversity, Equity, and Inclusion (DEI) to lead DEI initiatives that foster an inclusive and anti-racist environment for all members and employees of the MCC. The position has been established to support the National Cancer Institute’s commitment to ensure that (1) all Americans share equally in the medical advances that result from cancer research and (2) current disparities in the cancer burden are reduced or eliminated. As such, the position will provide strategic leadership, coordination, and implementation of DEI-related programs, initiatives, policies, and evaluative activities to enhance the diversity of MCC staff, faculty, students, and leadership.
For more information on this exciting opportunity, please visit the link below.
MORE INFO
|
|
|
Accepting Applications for Vice Chair, Data and Safety Monitoring Committee (DSMC)
|
|
|
| Compensation
Effort: 5% up to NIH cap
Required Qualifications
Faculty member of UCSD, SDSU, or LJI with experience as a PI of a cancer clinical trial
Moores Cancer Center (MCC) Member
Experience as PI/Site PI of Phase I/II investigator-initiated trials
Preferred Qualifications
An ideal candidate would have experience in both industry sponsored and investigator-initiated cancer therapeutics trials
Detail oriented
Committed to maintaining the integrity of clinical trials at MCC and executing the Data Safety and Monitoring Plan as written in the Cancer Center Support Grant
Time Commitment
2-4 hours per month for Committee meetings plus time to review material prior to meetings; more depending on level of involvement with other projects or potential of ad hoc reviews
Term
Recommended to be 3 years
MORE INFO
|
|
|
V Foundation for Cancer Research Grant Award
|
|
|
Kathryn Fowler, M.D.
Diagnostic Radiologist
Professor of Radiology
UC San Diego, School of Medicine, Department of Radiology
|
|
Congratulations to Dr. Kathryn Fowler on her recent $600,000 grant from the V Foundation for Cancer Research.
Dr. Fowler's 2022 Translational Award Program grant application, “Screening Ultrasound for Early Detection of Liver Cancer,” will be paid in three installments.
|
|
|
A Record-Breaking Year!
$3.2 Million Raised for Cancer Research
|
|
|
Curebound, a San Diego-based 501(c)(3) philanthropic organization that raises and invests strategic funding in translational cancer research projects, announced a record-breaking fundraising year for Padres Pedal the Cause.
Held on April 9, 2022 at Petco Park, the signature event raised $3,209,521 and brought 2,200 participants together in the fight against cancer for one of southern California’s largest stand-alone cancer fundraising events.
Operated in partnership with the San Diego Padres, Padres Pedal is San Diego’s most impactful fundraising experience, with more than $18 million raised to date to fund 80 innovative research grants that address all types of cancer.
|
|
|
Nominate an Emerging Leader in Immunology and Cancer Immunotherapy
|
|
|
|
The Society for Immunotherapy of Cancer (SITC) is pleased to announce the call for nominations for the 2022 Steven A. Rosenberg Scholars Award, one of the society's most prestigious opportunities for early career scientists.
SITC is seeking the best and brightest to continue Dr. Rosenberg’s legacy with a research award for early career scientists who are interested in tackling the challenges that face the field of cancer immunotherapy. Nominations are due July 15, 2022 and will be accepted via email to development@sitcancer.org.
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT
|
|
|
Monday, July 20, 2022
2:00 p.m. - 3:00 p.m.
Virtual Workshop: "Federal Grant Opportunities in Healthcare"
Moores Cancer Center is partnering with the Office of Congressman Scott Peters to present a panel for those in the community who would like to learn more about how to apply to federal grants.
Speakers include Dr. James Murphy and Dr. Elena Martinez, who will be sharing insights and experiences in this process.
ZOOM MEETING LINK
|
|
|
Thursday, July 23, 2022
9:00 a.m. - 10:00 a.m.
"Keeping Kids Healthy: HPV Vaccinations"
Moores Cancer Center is partnering with Assembly Member Dr. Akilah Weber’s office to present HPV vaccination information to the community.
Speakers
Maya Kumar, M.D., UC San Diego Health
Mike West, J.D., HPV Cancer Survivor and Advocate
Andrew Gonzalez, Champions for Health
Registration link to come!
|
|
|
August 1–5: California HPV Vaccine Week
Look out for events and information on HPV vaccination learning opportunities! Partner Assemblymember Dr. Akilah Weber is introducing a resolution in the state assembly. Be sure to follow us on Twitter @UCSDCancer_COE for updates. More to come!
MORE INFO
|
|
|
Saturday, August 13, 2022
"Backpack Giveaway and HPV Vaccination Clinic"
Moores Cancer Center is partnering with Assembly Member Dr. Akilah Weber’s office to make HPV vaccinations available via our community partner Champions for Health. Cancer education also will be provided at the event.
Time and location to come!
|
|
|
HIGHLIGHTED FUNDING OPPORTUNITY
|
|
|
DOD Breast Cancer Research Program: Transformative Breast Cancer Consortium Award
$25M direct for up to 4 years
The U.S. Department of Defense, Transformative Breast Cancer Consortium Award is designed to support collaborations and ideas that will transform the lives of individuals with, and/or at risk for, breast cancer and accelerate progress toward ending breast cancer. Applicants must bring together different perspectives to develop new paradigms that will solve fundamental yet overarching problems in breast cancer.
Pre-Application Deadline: August 8, 2022
MORE INFO
|
|
|
OTHER FUNDING OPPORTUNITIES
|
|
|
CA22-015 Cancer Control Research in Persistent Poverty Areas (U54 Clinical Trial Optional)
Award: $1.5M direct/year for up to 5 years
To provide resources to support the time and effort of transdisciplinary teams, in collaboration with institutions, clinics, and communities/tribes, to develop a cancer prevention and control research program and provide support to early-career investigators that targets and serves populations living in persistent poverty areas.
Deadline: July 6, 2022
MORE INFO
|
Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54)
Award: With support from the FDA Center for Tobacco Products (CTP), expects to fund eight TCORS, corresponding to a total of $32 million, for fiscal year 2023
Future year amounts will depend on the availability of funds.
Deadline: July 14, 2022
MORE INFO
|
CA22-017 Small Business Transition Grant for Early Career Scientists (R42 Clinical Trial Not Allowed)
Award: Total $275,766 for Phase I awards; $1,838,436 for Phase II awards (NCI 2 years each)
To support not only early-career academic scientists interested in transitioning to entrepreneurship, but also the transfer of technology from academic laboratories to small businesses.
Deadline: August 22, 2022
MORE INFO
|
Administrative Supplements to Support Cancer Disparity Collaborative Research
Award: $150,000 direct for 1 year
The purpose of this trans-NCI Funding Opportunity Announcement (FOA) is to (1) promote new cancer disparities research among investigators who do not normally conduct it and (2) encourage the partnership of experienced cancer research investigators with cancer disparities-focused researchers. Cancer disparities research includes, but is not limited to, basic, translational, behavioral, observational, interventional, environmental, and population research studies that address the adverse differences in cancer incidence, prevalence, mortality, survivorship, burden, and/or response to treatment in racial/ethnic minorities and/or underserved populations.
Deadline: September 6, 2022
|
MD22-008 Understanding and Addressing Misinformation among Populations that Experience Health Disparities (R01 - Clinical Trials Optional)
Award: $500K direct/year for up to 5 years
To support research that seeks to (1) understand the underlying mechanisms and (2) test interventions that address and mitigate the impact of health-related misinformation and disinformation on health disparities and the populations that experience health disparities.
Deadline: November 13, 2022
MORE INFO
|
Early-Stage/Advanced/Sustained Development of Informatics Technologies for Cancer Research and Management (R21/U01/U24 Clinical Trial Optional
Award: $275K unlimited direct costs 2-5 years, depending on mechanism
This component of the NCI's Informatics Technology for Cancer Research (ITCR) Program targets the development of enabling informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum.
Deadline: November 17, 2022
|
|
|
DOD Breast Cancer Research Program (BCRP): Anticipated Funding Opportunities
These U.S. Department of Defense BCRP awards will support innovative, high-impact research, with a mission of ending breast cancer for service members, veterans, and the general public. Funding mechanisms will include Breakthrough Awards, Era of Hope Scholar Awards, and Innovator Awards.
MORE INFO
|
|
|
FOUNDATION FUNDING OPPORTUNITIES
|
|
|
The Innovation Award
This award is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea yet lack sufficient preliminary data to obtain traditional funding; the award is not designed to fund incremental advances. The research supported by the award must be novel, exceptionally creative, and, if successful, possess strong potential for high impact in the cancer field.
Deadline: July 6, 2022
MORE INFO
|
|
|
Mark Foundation for Cancer Research: Endeavor Collaborative Research Awards
$3,000,000 for 3 years
The Mark Foundation Endeavor Awards support collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis, and treatment of cancer. These grants are awarded to teams of three or more investigators to (1) generate and integrate data from diverse lines of research and (2) transform those insights into advances for cancer patients that could not be achieved by individual efforts. A description of the teams granted Endeavor Awards in 2022 can be found here.
MORE INFO
|
|
|
|
Tuesday, October 11, 2022
UC San Diego, Moores Cancer Center
Delivering Discoveries Annual Scientific Retreat
Location: Scripps Seaside Forum
8610 Kennel Way, La Jolla, CA 92037
|
|
|
Thursday to Friday, October 20-21, 2022
Time: TBD
Sanford Stem Cell Annual Symposium co-hosted by Moores Cancer Center, Hematologic Malignancies Program
Location: Sanford Consortium, Duane J. Roth Auditorium
2880 Torrey Pines Scenic Drive, La Jolla, CA 92037
-
Recent breakthroughs in regenerative medicine
- Stem cell regeneration in several disease areas
- Interactive discussion panels regarding stem cells in space and stem cell clinical trials
Hosted by
Catriona Jamieson, M.D., Ph.D., Deputy Director of Moores Cancer Center, Director of the Sanford Stem Cell Clinical Center, and Chief of the Division of Regenerative Medicine and Alysson Muotri, Ph.D., Co-Director, Stem Cell Program
Keynote Speakers
Derrick Rossi, Ph.D., Co-Founder, Moderna; Elizabeth Blackburn, Ph.D., Professor, UC San Francisco; and Thomas C. Sudhof, M.D., Professor, Stanford University
MORE INFO
|
Tuesday to Saturday, November 8-12, 2022
Join Us in Person at SITC 2022
37th Annual Meeting & Pre-Conference Programs
Location: Boston Convention and Exhibition Center, Boston, MA. Virtual participation also available at the same registration rates.
REGISTER TODAY!
|
Saturday, January 28, 2023
Prostate Cancer Patient Summit
More information to come!
|
|
|
Newly opened clinical trials (June, 2022)
|
|
|
- SRA3, Req #117074
-
RA2, Post Award (candidates hired into this position can work remotely, in-person or hybrid). Req #117071
-
RA3 or RA2, Pre-Award (candidates hired into this position can work remotely, in-person or hybrid). – Req #116028
-
Financial Analyst 1 – Req #116694
- Financial Analyst 2 – Req #117186
|
|
|
If you have newsworthy items to contribute, please contact our Marketing & Communications Manager, Renee Maude at amaude@health.ucsd.edu.
|
|
|
Moores Cancer Center (MCC) is not only one of only 52 National Cancer Institute (NCI)-designated comprehensive cancer centers in the nation, but also the only one providing multidisciplinary, research-driven detection, treatment, survivorship, and prevention of cancer in San Diego County. The 360 MCC member scientists and clinicians hail from 22 UC San Diego specialty departments, Rady Children’s Hospital, San Diego State University, and the La Jolla Institute of Immunology.
With strengths in stem cell research, immune-oncology, precision medicine, cancer disparities, and pre-cancer and risk research, MCC researchers address translational oncology and drug development through partnerships with biotechnology and pharmaceutical companies. MCC was founded in 1978, the same year it received its NCI designation.
|
|
|
Department of Research Administration
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
3855 Health Sciences Drive MC 0698 | La Jolla, CA 92093 US
|
|
|
This email was sent to .
To continue receiving our emails, add us to your address book.
|
|
|
|
